IPO Blowout Forecast for 2025 Threatened By Trump Tariffs

(Bloomberg) -- Stock markets have been cheering the return of Donald Trump and shrugging off the prospect of tariffs that he’s long promised to impose on America’s biggest trading partners.

Most Read from Bloomberg

IPO bankers, who for months have been helping companies gear up for what’s expected to be a standout year for debuts, have a humble plea for the president-elect: Could he just stay out of the market’s way?

Even after a year in which volume has jumped more than 60% versus in 2023, US initial public offerings are still recovering from a streak of interest rate hikes that slammed the door on pandemic-era stimulus and triggered a stock market correction. While the exact timing for a return to normal is up for debate, all eyes are on 2025, so long as the incoming administration’s policies don’t throw cold water on it.

“The biggest risk is it creates unneeded volatility in the market as a whole,” said Clay Hale, co-head of equity capital markets at Wells Fargo & Co. “When there’s volatility in the market and investors are focused on their portfolio, they’re less likely to want to engage in adding a company from the private markets.”

Taking a company public has been compared to steering an aircraft carrier: It takes time to get documents in order, engage with investors and clean up the balance sheet. With volatility mostly absent for the better part of a year, dealmakers have had time to prepare for marquee listings like CoreWeave, Medline Industries Inc. and Genesys Cloud Services Inc. that may raise single-digit billions of dollars.

A flurry of large deals next year could blow past the $43 billion raised through first time share sales this year on US exchanges, data compiled by Bloomberg show.

Still, even with markets hanging near record highs amid expectations of a strong economy and more growth on the horizon, “some uncertainty still lingers,” according to Kevin Foley, JPMorgan Chase & Co.’s global head of capital markets.

“There’s optimism that the new administration will bring deregulation and reduce inflation, but tariffs are inherently inflationary,” Foley said in an interview.

Private Equity Dilemma

The return of sharply rising prices would force the Federal Reserve to rethink the interest rate path. That could worsen the dilemma for private equity firms with a logjam of companies to take public or sell sitting at nearly $3 trillion as of October, not to mention debt service costs that would likely keep rising.

“A lot of the activity will come from the private equity community,” said Arnaud Blanchard, global co-head of equity capital markets at Morgan Stanley, whose firm is working on a pipeline of buyout firm-backed deals. “But this isn’t a 2020 market, and it will still favor high-quality assets, where the amounts raised and implied market caps are not sub scale.”